Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$29.0B
1,798M shares
52-week range
$14.92 – $34.08
6% from low
Sector
RETAIL-CATALOG & MAIL-ORDER HOUSES
Exchange
NYSE
CS
Coupang is South Korea's largest e-commerce platform that sells both owned and third-party inventory. Headquartered in the US, Coupang operates e-commerce businesses mainly in South Korea and Taiwan. The company has built an integrated logistics network that covers the entirety of South Korea, with extensive fulfillment centers that ensure timely delivery, even for orders placed seconds before midnight. Outside of its bread-and-butter e-commerce business, Coupang has expanded into Rocket delivery services to third-party merchants (fulfillment and logistics by Coupang), online grocery delivery Rocket Fresh, online meal delivery (Eats), e-commerce in Taiwan, luxury e-commerce (Farfetch), and travel.
www.aboutcoupang.comNo one on the platform currently holds CPNG.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2025-12-31 | 1,554,380 | $36.7M |
| Bridgewater Associatesas of 2025-12-31 | 84,210 | $2.0M |
No one on the platform has traded CPNG yet.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$SE only good thing about being red today is $MELI tanked hard, hopefully we stop getting jerked around by that piece of shit stock, took us a while to shake off garbage $CPNG but we did that too.
View on StockTwits ↗$CPNG I think LGVN could be the next Sandisk of the biotech world LGVN fully diluted market cap $40 million - $2 billion annual potential revenues (only US and Europe (untapped)) times a p/s of 8 -> $16 billion market cap, for only HLHS (unmet medical need...Hypoplastic Left Heart Syndrome...HLHS phase 2 results August 2026) Extremely promising Alzheimer's results phase 2, in talks for partner for phase 3 green light from FDA to start phase 2 Pediatric Dilated Cardiomyopathy (multi-billion revenue potential) Great results phase 2 Aged related frailty In recent presentation, Longeveron compares itself to stem cell companies, Mesoblast and Capricor both recently valued over $2 billion. I think Longeveron has more potential 50 patents 60 patents pending HLHS program may be eligible for PRV (priority review voucher) upon BLA approval (valued between $150-200 million)
View on StockTwits ↗$CPNG is still growing its developing offerings fast . The core commerce story is expanding . But when a platform adds new revenue lines this quickly , the real question is whether the margins follow . Growth is easy . Profitable growth is hard . Let the next print prove it .
View on StockTwits ↗$CPNG Turn that frown upside down, fellas. Back at 16.
View on StockTwits ↗$CPNG just waiting patiently for them to drop this like a rock
View on StockTwits ↗$CPNG by years end company will start showing corner turn , for now doomed
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $37.0B | +6.4% | $-0.46 | $-0.54–$-0.31 | — | 6 |
| 2027 | $42.1B | +13.7% | $0.33 | $0.18–$0.41 | 49.3× | 8 |
| 2028 | $47.2B | +12.1% | $0.71 | $0.31–$1.15 | 22.6× | 14 |
| 2029 | $48.4B | +2.4% | $0.55 | $0.53–$0.58 | 29.3× | 7 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 4 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-04 | $-0.27 | $-0.32 | -19.0% |
| 2026-05-05 | $-0.09 | $-0.15 | -60.7% |
| 2026-02-26 | $0.03 | $-0.01 | -134.5% |
| 2025-11-04 | $0.04 | $0.05 | +36.5% |
| 2025-08-05 | $0.07 | $0.02 | -69.7% |
| 2025-05-06 | $0.05 | $0.06 | +12.2% |
| 2025-02-25 | $0.01 | $0.04 | +300.0% |
| 2024-11-05 | $0.01 |
| $0.06 |
| +400.0% |
| — |
| GMGeneral Motors Company | $86.77 | +0.44% | $78.5B | — |
| HLTHilton Worldwide Holdings Inc. | $327.21 | +1.99% | $73.6B | — |
Source: Financial Modeling Prep · peers by sector/industry